Japan Drug Firms’ Average Overseas Sales Ratio Nearly 50%, Offshore Biz Remains Way to Go as Home Market Falters: Tally

Japanese drug makers pulled in an average 49.2% of their sales from overseas in FY2018, according to a Jiho tally. The ratio was heavily swung by Takeda Pharmaceutical’s Shire acquisition, to be sure, but even excluding this factor, beefing up...read more